Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (181-190 of 410) with videos related to

Pageof 41
Sort By:
Science Immunology|February 3, 2019
Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in childrenAlexandra Paun, Christopher Yau, Shahab Meshkibaf, et al.
Trends in Molecular Medicine|December 22, 2019
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging ImmunotherapiesAmit Bar-Or, Michael P Pender, Rajiv Khanna, et al.
The Journal of Clinical Investigation|August 5, 2003
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer diseaseAlon Monsonego, Victor Zota, Arnon Karni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 21, 2016
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatmentUlrike Bühler, Vinzenz Fleischer, Felix Luessi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2017
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MSVinzenz Fleischer, Michaela Friedrich, Ayman Rezk, et al.
Annals of Neurology|July 28, 2010
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosisPeter J Darlington, Marie-Noëlle Boivin, Christel Renoux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelinationNaila Makhani, Brenda Banwell, Raymond Tellier, et al.
Journal of Neurology|October 2, 2014
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE studyDouglas L Arnold, Ralf Gold, Ludwig Kappos, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trialJeffrey A Cohen, Douglas L Arnold, Giancarlo Comi, et al.
Brain : a Journal of Neurology|September 25, 2003
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosisAmit Bar-Or, Robert K Nuttall, Martin Duddy, et al.
Pageof 41

Showing results (181-190 of 410) with videos related to

Sort By:
Pageof 41
Science Immunology|February 3, 2019
Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in childrenAlexandra Paun, Christopher Yau, Shahab Meshkibaf, et al.
Trends in Molecular Medicine|December 22, 2019
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging ImmunotherapiesAmit Bar-Or, Michael P Pender, Rajiv Khanna, et al.
The Journal of Clinical Investigation|August 5, 2003
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer diseaseAlon Monsonego, Victor Zota, Arnon Karni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 21, 2016
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatmentUlrike Bühler, Vinzenz Fleischer, Felix Luessi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2017
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MSVinzenz Fleischer, Michaela Friedrich, Ayman Rezk, et al.
Annals of Neurology|July 28, 2010
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosisPeter J Darlington, Marie-Noëlle Boivin, Christel Renoux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelinationNaila Makhani, Brenda Banwell, Raymond Tellier, et al.
Journal of Neurology|October 2, 2014
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE studyDouglas L Arnold, Ralf Gold, Ludwig Kappos, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trialJeffrey A Cohen, Douglas L Arnold, Giancarlo Comi, et al.
Brain : a Journal of Neurology|September 25, 2003
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosisAmit Bar-Or, Robert K Nuttall, Martin Duddy, et al.
Pageof 41